Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0155 USD
3.10 M USD
16.00 M USD
180.62 M
About CV Sciences, Inc.
Sector
CEO
Joseph D. Dowling
Headquarters
San Diego
Website
Founded
2010
FIGI
BBG0022J68R8
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the following segments: Consumer Products and Specialty Pharmaceutical. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CVSI is 0.0456 USD — it has decreased by −0.76% in the past 24 hours. Watch CV Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CV Sciences, Inc. stocks are traded under the ticker CVSI.
CVSI stock has risen by 2.36% compared to the previous week, the month change is a 1.22% rise, over the last year CV Sciences, Inc. has showed a 50.33% increase.
CVSI reached its all-time high on Feb 21, 2014 with the price of 201.0000 USD, and its all-time low was 0.0263 USD and was reached on Dec 29, 2022. View more price dynamics on CVSI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CVSI stock is 11.63% volatile and has beta coefficient of −0.44. Track CV Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is CV Sciences, Inc. there?
Today CV Sciences, Inc. has the market capitalization of 8.29 M, it has decreased by −2.58% over the last week.
Yes, you can track CV Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
CV Sciences, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
CVSI net income for the last quarter is −584.00 K USD, while the quarter before that showed −628.00 K USD of net income which accounts for 7.01% change. Track more CV Sciences, Inc. financial stats to get the full picture.
No, CVSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 43.00 employees. See our rating of the largest employees — is CV Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CV Sciences, Inc. EBITDA is −1.92 M USD, and current EBITDA margin is −13.90%. See more stats in CV Sciences, Inc. financial statements.
Like other stocks, CVSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CV Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CV Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CV Sciences, Inc. stock shows the sell signal. See more of CV Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.